524414 NORRIS

Norris Medicines Share PriceNorris Medicines

₹12.51
0.01 (0.08%)
As on 02 December, 2023 | 07:29 BSE: 524414 NSE: NORRISISIN: INE744C01029

Norris Medicines Performance

Day Range

  • Low
  • High
₹ 12.51

52 Week Range

  • Low
  • High
₹ 12.51
  • Open Price
  • Previous Close
  • Volume

Start SIP in Norris Medicines

Start SIP

Norris Medicines Share Price

  • Over 1 Month 7.75%
  • Over 3 Month 11.8%
  • Over 6 Month 4.25%
  • Over 1 Year -5.87%

Norris Medicines Key Statistics

Norris Medicines Investment Rating

  • Master Rating:
  • Norris Medicines has an operating revenue of Rs. 7.88 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of -14% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 3113311
Operating Expenses Qtr Cr 3113311
Operating Profit Qtr Cr 0010000
Depreciation Qtr Cr 0000001
Interest Qtr Cr 0000100
Tax Qtr Cr 0010001
Net Profit Qtr Cr 0-1-10-10-2
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 89
Operating Expenses Annual Cr 710
Operating Profit Annual in Cr 10
Depreciation Cr 11
Interest Annual Cr 21
Tax Annual Cr 11
Net Profit Annual Cr -2-3
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -1
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 1
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr -12-11
Fixed Assets Annual Cr 67
Total Non Current Assets Annual Cr 910
Total Current Assets Annual Cr 54
Total Assets Annual Cr 1414
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs -13-11
ROE Annual % 00
ROCE Annual % 5-9
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 110
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Norris Medicines Technicals

EMA & SMA

Current Price
₹12.51
0.01 (0.08%)
pointer
  • Bullish Moving Average
  • ___
  • 13
  • Bearish Moving Average
  • ___
  • 3
  • 20 Day
  • ₹12.23
  • 50 Day
  • ₹11.91
  • 100 Day
  • ₹11.85
  • 200 Day
  • ₹12.00
  • 20 Day
  • ₹12.04
  • 50 Day
  • ₹11.76
  • 100 Day
  • ₹11.78
  • 200 Day
  • ₹11.87

Norris Medicines Resistance and Support

PIVOT
₹12.78
Resistance
First Resistance 13.04
Second Resistance 13.26
Third Resistance 13.53
RSI 58.56
MFI 85.49
MACD Single Line 0.24
MACD 0.37
Support
First Resistance 12.55
Second Resistance 12.28
Third Resistance 12.06

Norris Medicines Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,243 68,800 55.35
Week 1,894 124,793 65.88
1 Month 1,906 144,620 75.88
6 Month 1,783 138,134 77.49

Norris Medicines Result Highlights

Norris Medicines Synopsis

Market Cap
Sales
Shares in Float
No of funds
Yield
Book Value
U/D Vol ratio
LTDebt / Equity
Alpha
Beta

Norris Medicines

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 34.01%34.01%34.04%34.04%
Mutual Funds 0.01%0.01%0.01%0.01%
Financial Institutions/ Banks 0.06%0.06%0.06%0.06%
Individual Investors 20.66%20.62%20.55%20.59%
Others 45.26%45.3%45.34%45.3%

Norris Medicines Management

Name Designation
Mr. Vimal Shah Managing Director
Mrs. Susmita Mahapatra Woman Director
Dr. Hiten Parikh Director
Mr. Shaikh Amanullah Mohamed Azmathullah Director

Norris Medicines Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Norris Medicines Corporate Action

Date Purpose Remarks
2023-11-18 A.G.M.
2023-11-10 Quarterly Results
2023-08-10 Quarterly Results
2023-05-25 Audited Results
2023-02-13 Quarterly Results

Norris Medicines FAQs

What is Share Price of Norris Medicines ?

Norris Medicines share price is ₹12 As on 02 December, 2023 | 07:15

What is the Market Cap of Norris Medicines ?

The Market Cap of Norris Medicines is ₹12.5 Cr As on 02 December, 2023 | 07:15

What is the P/E ratio of Norris Medicines ?

The P/E ratio of Norris Medicines is -6.8 As on 02 December, 2023 | 07:15

What is the PB ratio of Norris Medicines ?

The PB ratio of Norris Medicines is -1 As on 02 December, 2023 | 07:15

Q2FY23